accountkeep generics of the market are already costing consumers and taxpayers $3.5 billion a year in higher drug prices,��� Leibowitz said today in a statement. ���The increasing number of these deals is a win-win proposition for the pharmaceutical industry,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FTC���s Leibowitz Denounces Patent Accords That Delay Generics
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account